Zobrazeno 1 - 10
of 789
pro vyhledávání: '"Schallier, D."'
Autor:
Collen, C. *, Christian, N., Schallier, D., Meysman, M., Duchateau, M., Storme, G., De Ridder, M.
Publikováno v:
In Annals of Oncology October 2014 25(10):1954-1959
Autor:
Gondry O; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium; odrade.gondry@uzbrussel.be.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Xavier C; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Raes L; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Heemskerk J; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Devoogdt N; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium., Everaert H; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Breckpot K; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Lecocq Q; Laboratory for Molecular and Cellular Therapy, Vrije Universiteit Brussel, Brussels, Belgium., Decoster L; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Fontaine C; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Schallier D; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Aspeslagh S; Department of Medical Oncology, Universitair Ziekenhuis Brussel, Brussels, Belgium., Vaneycken I; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Raes G; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Van Ginderachter JA; Cellular and Molecular Immunology, Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium; and.; Myeloid Cell Immunology Lab, VIB Center for Inflammation Research, Brussels, Belgium., Lahoutte T; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Caveliers V; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium., Keyaerts M; MIMA, Department of Medical Imaging, Vrije Universiteit Brussel, Brussels, Belgium.; Nuclear Medicine Department, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Sep; Vol. 64 (9), pp. 1378-1384. Date of Electronic Publication: 2023 Jul 20.
Autor:
Fontaine, C., Meulemans, A., Huizing, M., Collen, C., Kaufman, L., De Mey, J., Bourgain, C., Verfaillie, G., Lamote, J., Sacre, R., Schallier, D., Neyns, B., Vermorken, J., De Grève, J.
Publikováno v:
In The Breast 2008 17(4):376-381
Autor:
Decoster, L., Schallier, D., Everaert, H., Nieboer, K., Meysman, M., Neyns, B., De Mey, J., De Grève, J.
Publikováno v:
In Lung Cancer 2008 62(1):55-61
Autor:
Schallier, D., Neyns, B., Fontaine, C., Steene, J. Vande, De Mey, J., Meysman, M., De Grève, J.
Publikováno v:
In Lung Cancer 2007 56(2):247-254
Publikováno v:
Journal of Immunology Research; 5/8/2018, p1-5, 5p, 3 Charts, 2 Graphs
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fontaine, C., Joris, S., Decoster, L., Vanacker, L., Schallier, D., Vanhoeij, M., Verfaillie, G., Lamote, J., De Grève, J.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3848::fe250c6fa53ba377395accee51ea2f5f
https://hdl.handle.net/20.500.14017/c2e1a963-9908-4227-855b-b267fc81f65a
https://hdl.handle.net/20.500.14017/c2e1a963-9908-4227-855b-b267fc81f65a
Autor:
Motzer, Robert J, Escudier, Bernard, McDermott, David F, George, Saby, Hammers, Hans J, Srinivas, Sandhya, Tykodi, Scott S, Sosman, Jeffrey A, Procopio, Giuseppe, Plimack, Elizabeth R, Castellano, Daniel, Choueiri, Toni K, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C, Ueda, Takeshi, Tomita, Yoshihiko, Schutz, Fabio A, Kollmannsberger, Christian, Larkin, James, Ravaud, Alain, Simon, Jason S, Xu, Li-An, Waxman, Ian M, Sharma, Padmanee, CheckMate 025 Investigators, Schallier, D, Schallier, Denis
Publikováno v:
Motzer, R J, Escudier, B, McDermott, D F, George, S, Hammers, H J, Srinivas, S, Tykodi, S S, Sosman, J A, Procopio, G, Plimack, E R, Castellano, D, Choueiri, T K, Gurney, H, Donskov, F, Bono, P, Wagstaff, J, Gauler, T C, Ueda, T, Tomita, Y, Schutz, F A, Kollmannsberger, C, Larkin, J, Ravaud, A, Simon, J S, Xu, L-A, Waxman, I M, Sharma, P & CheckMate 025 Investigators 2015, ' Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma ', The New England Journal of Medicine, vol. 373, no. 19, pp. 1803-13 . https://doi.org/10.1056/NEJMoa1510665
NEW ENGLAND JOURNAL OF MEDICINE
NEW ENGLAND JOURNAL OF MEDICINE
BACKGROUND: Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated with encouraging overall survival in uncontrolled studies involving previously treated patients with advanced renal-cell carcinoma. This randomized, open-label, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a331349b83f68cef9dbae547a13cd8e3
https://www.ncbi.nlm.nih.gov/pubmed/26406148
https://www.ncbi.nlm.nih.gov/pubmed/26406148
Autor:
Joris S; Department of Medical Oncology, Oncologisch Centrum, UZ Brussel, Vrije Universiteit Brussel, Brussel, Belgium., Pieters T; Cliniques Universitaires Saint-Luc UCL, Brussel, Belgium., Sibille A; Department of pulmonology, CHU de Liège, ULiège, Liège, Belgium., Bustin F; Department of pulmonology, CHR de La Citadelle, Liège, Belgium., Jacqmin L; Department of pulmonology, Clinique Saint-Luc Bouge, Namur, Belgium., Kalantari HR; Department of pulmonology, CHR Verviers, Verviers, Belgium., Surmont V; Department of pulmonology, UZ Gent, Gent, Belgium., Goeminne JC; Department of medical oncology, CHU-UCL-Namur Site Sainte Elisabeth, Namur, Belgium., Clinckart F; Department of pulmonology, Hopital de Jolimont, Jolimont, Belgium., Pat K; Department of pulmonology, Jessa Ziekenhuis, Hasselt, Belgium., Demey W; Department of medical oncology, AZ Klina, Brasschaat, Belgium., Deschepper K; Department of pulmonology, AZ Nikolaas, Sint Niklaas, Belgium., Lambrechts M; Department of pulmonology, AZ Sint Maarten, Mechelen, Belgium., Holbrechts S; Department of medical oncology, CHU Ambroise Paré, Mons, Belgium., Schallier D; Department of Medical Oncology, Oncologisch Centrum, UZ Brussel, Vrije Universiteit Brussel, Brussel, Belgium., Decoster L; Department of Medical Oncology, Oncologisch Centrum, UZ Brussel, Vrije Universiteit Brussel, Brussel, Belgium. Electronic address: lore.decoster@uzbrussel.be.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2020 Jun; Vol. 11 (5), pp. 796-801. Date of Electronic Publication: 2019 Nov 30.